A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The study is a Phase 2a, randomized, double-blind, placebo-controlled, sequential cohort study to evaluate the pharmacodynamics (PD), safety and pharmacokinetics (PK) of multiple doses of SRSD107 in participants with coronary arterial disease (CAD) and/or peripheral arterial disease (PAD) with aspirin as background concomitant therapy.
Epistemonikos ID: e61e69c436a946c9f2db42b6e52b1e1950c925a9
First added on: Jan 06, 2026